Company releases

Inside information: Nightingale Health and Terveystalo sign letter of intent to expand strategic partnership

Jun 30, 2023
Press releases

World's largest population study combining blood biomarkers and genetics demonstrates Nightingale Health's risk prediction models outperform genetic risk prediction in chronic diseases

Jun 15, 2023
Press releases

Nightingale Health’s strategic collaboration with UK Biobank progresses: Biomarker results of additional 200,000 blood samples soon available to researchers globally

Jun 06, 2023
Company releases

Nightingale Health Plc’s financial reporting and Annual General Meeting in financial year 2023 – 2024

May 31, 2023
Press releases

Nightingale Health has received six patent approvals for its proprietary health risk detection platform

May 23, 2023
Company releases

Maximilian LeRoux appointed as Chief Commercial Officer of Nightingale Health Plc

May 08, 2023
Company releases

Nightingale Health Plc: Resolutions of the Extraordinary General Meeting and the Board of Directors’ organizational meeting

Apr 24, 2023

Livit by Nightingale Health reaches even more users

Mar 29, 2023
Company releases

Nightingale Health Plc’s Auditor to Change

Mar 24, 2023
Company releases

Nightingale Health Group’s Half-year report 1 July 2022 – 31 December 2022: Commercialization progressing in line with strategy

Mar 23, 2023
Company releases

Nightingale Health Plc: Unaudited financial information in accordance with IFRS for the comparative half-year periods

Mar 22, 2023
Company releases

Notice to the Extraordinary General Meeting of Nightingale Health Plc

Mar 17, 2023
Press releases

Nightingale Health to publish half-year report for July – December 2022 on 23 March 2023

Mar 15, 2023
Press releases

Strategic collaboration in Estonia progresses: Nightingale Health completes the analysis of 200,000 Estonian Biobank samples

Mar 08, 2023
Managers' transactions

Nightingale Health Plc – Managers’ transactions – Olli Karhi

Feb 14, 2023